CLOV Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Clover Health Investments Corp (CLOV) is not a strong buy at the moment for a beginner investor with a long-term focus. While the company has shown significant revenue growth and improvement in net income, the technical indicators are bearish, and there are no strong positive catalysts or trading signals to suggest immediate upside potential. Holding off on investment until clearer positive trends emerge would be prudent.
The technical indicators for CLOV are bearish. The MACD is below zero and negatively contracting, the RSI is neutral at 25.767, and the moving averages show a bearish trend (SMA_200 > SMA_20 > SMA_5). The stock is trading near its support level (S1: 2.031), with resistance levels at R1: 2.245 and R2: 2.311. Overall, the technical outlook does not suggest a strong buying opportunity.
The company's financial performance in Q3 2025 showed strong revenue growth of 50.05% YoY and significant improvement in net income (+166.27% YoY) and EPS (+150.00% YoY).
No recent news or significant events to drive positive sentiment. Technical indicators are bearish, and there are no recent trading trends from hedge funds, insiders, or Congress. The stock's historical performance suggests limited short-term upside potential.
In Q3 2025, Clover Health reported revenue of $496.65M, up 50.05% YoY. Net income improved to -$24.38M (+166.27% YoY), and EPS increased to -0.05 (+150.00% YoY). Gross margin remained stable at 100%. While the financials show improvement, the company is still not profitable.
No recent analyst rating or price target changes were provided. Wall Street sentiment appears neutral, with no strong pros or cons highlighted.
